Evidence-based Solutions Under Development

AUGUST 01, 2006

Thomson Micromedex and Geisinger Health System are partnering to create comprehensive evidence-based order sets (medication instructions and treatment options) that health care organizations can use to regulate and improve patient care, quality, outcomes, and efficiencies. Through this alliance, Micromedex will acquire a considerable collection of proven inpatient order sets from Geisinger. The 2 companies will then work on products that integrate these established proven medical protocols with evidence- based clinical knowledge solutions.

The new product, Micromedex Order Sets, will address health care organizations' needs for detailed instructions and treatment options that mirror current standards, medical evidence, and quality and regulatory initiatives for the most frequent hospital and emergency department diagnoses, procedures, and complaints. Currently, the hospitals throughout Canada and the United States using Micromedex knowledge products can apply Micromedex Order Sets work-flow capabilities to maintain a clinically consistent knowledge base. The sets will include a customization tool that links to a variety of Micromedex evidence-based clinical decision support modules to help health care organizations adapt and tailor the product to their own hospital policies and procedures.




SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.